Glucose impairments and insulin resistance in prostate cancer: the role of obesity, nutrition and exercise.
Katie M Di SebastianoJ H PinthusW C M DuivenvoordenM MourtzakisPublished in: Obesity reviews : an official journal of the International Association for the Study of Obesity (2018)
Independently evaluating changes in glucose metabolism near the time of prostate cancer diagnosis and during long-term ADT treatment is important to distinguish their unique contributions to the development of metabolic disturbances. Integrative approaches, including metabolic, clinical and body composition measures, are needed to understand the role of adiposity and insulin resistance in prostate cancer and to develop effective nutrition and exercise interventions to improve secondary diseases in survivorship.